Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MSANTD3 pseudogene 1 (MSANTD3P1) is a processed pseudogene derived from the *Myb/SANT-like DNA-binding domain-containing protein 3* (MSANTD3) gene. Pseudogenes are non-coding DNA sequences that resemble protein-coding genes but are generally non-functional due to disabling mutations or a lack of regulatory elements[5][4][7]. MSANTD3P1 is identified in genomic studies based on homology and retrotransposition events but is not known to encode a protein or contribute to recognized biological processes or disease phenotypes. Unlike its parental gene, MSANTD3, which shows oncogenic potential in certain salivary gland cancers, the MSANTD3P1 pseudogene has no established functional, diagnostic, or therapeutic relevance[5][3][4][7]. If you are seeking information on an actionable biological target, consider searching for **MSANTD3** itself rather than its pseudogene form.
None. MSANTD3P1 is not a functional protein-coding gene, nor targeted by drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MSANTD3 pseudogene 1 (MSANTD3P1).